Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats

被引:0
作者
Asakura, H
Okudaira, M
Yoshida, T
Ontachi, Y
Yamazaki, M
Morishita, E
Miyamoto, K
Nakao, S
机构
[1] Kanazawa Univ, Sch Med, Dept Internal Med 3, Kanazawa, Ishikawa 9208641, Japan
[2] Kanazawa Univ, Hosp Pharm, Sch Med, Kanazawa, Ishikawa 9208641, Japan
[3] Kanazawa Univ, Sch Med, Dept Lab Med, Kanazawa, Ishikawa 9208641, Japan
关键词
disseminated intravascular coagulation; tissue factor; lipopolysaccharide; endothelin; nitric oxide;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have investigated the role of two vasoactive substances, nitric oxide (NO) and endothelin (ET), in the pathophysiology of disseminated intravascular coagulation (DIC), using two types of DIC models. Experimental DIC was induced by sustained infusion of 0.1, 1, 10, or 50 mg/kg lipopolysaccharide (LPS), or 3.75 U/kg thromboplastin (TF), for 4 It via the rat tail vein. Plasma levels of both NOX (metabolites of NO) and ET were significantly increased following infusion of 0.1 mg/kg or greater of LPS in the LPS-induced DIC rat model. In contrast, although a marked increase in the plasma levels of NOX was observed, only a slight increase in plasma ET levels was seen in the TF-induced DIC rat model. No significant differences in the plasma levels of platelets or thrombin-ATIII complex were observed among the TF-induced and LPS (50 mg/dl)-induced DIC models. However, plasma NOX levels rose significantly higher in the TF-induced model, relative to the LPS-induced model (p < 0.01). Conversely, plasma ET levels were significantly greater after LPS-induction, compared to TF-induction, of DIC (p < 0.01). Vasoconstriction, as well as depressed fibrinolytic activity, may be additional factors leading to severe organ dysfunction in the LPS-induced DIC rat model. Moreover, vasodilatation, as well as enhanced fibrinolytic activity, may help to prevent rats from severe organ dysfunction in the TF-induced DIC model. Our results suggest that modulator of vasoactive substances should be examined in the treatment of DIC.
引用
收藏
页码:663 / 667
页数:5
相关论文
共 35 条
[1]   ROLE OF ENDOTHELIN IN DISSEMINATED INTRAVASCULAR COAGULATION [J].
ASAKURA, H ;
JOKAJI, H ;
SAITO, M ;
UOTANI, C ;
KUMABASHIRI, I ;
MORISHITA, E ;
YAMAZAKI, M ;
MATSUDA, T .
AMERICAN JOURNAL OF HEMATOLOGY, 1992, 41 (02) :71-75
[2]   Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats [J].
Asakura, H ;
Suga, Y ;
Aoshima, K ;
Ontachi, Y ;
Mizutani, T ;
Kato, M ;
Saito, M ;
Morishita, E ;
Yamazaki, M ;
Takami, A ;
Miyamoto, K ;
Nakao, S .
CRITICAL CARE MEDICINE, 2002, 30 (01) :161-164
[3]   An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation [J].
Asakura, H ;
Ontachi, Y ;
Mizutani, T ;
Kato, M ;
Saito, M ;
Kumabashiri, I ;
Morishita, E ;
Yamazaki, M ;
Aoshima, K ;
Nakao, S .
CRITICAL CARE MEDICINE, 2001, 29 (06) :1164-1168
[4]  
BERGMEYER HU, 1978, CLIN CHEM, V24, P58
[5]   Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells - Role of cGMP in the regulation of the plasminogen system [J].
Bouchie, JL ;
Hansen, H ;
Feener, EP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1771-1779
[6]  
FEINSTEIN DI, 1982, BLOOD, V60, P284
[7]   AN IMMUNOLOGICAL METHOD FOR DEMONSTRATING FIBRIN DEGRADATION PRODUCTS IN SERUM AND ITS USE IN DIAGNOSIS OF FIBRINOLYTIC STATES [J].
FERREIRA, HC ;
MURAT, LG .
BRITISH JOURNAL OF HAEMATOLOGY, 1963, 9 (03) :299-&
[8]  
Förstermann U, 1998, FASEB J, V12, P773
[9]   Molecular biology of nitric oxide synthases [J].
Geller, DA ;
Billiar, TR .
CANCER AND METASTASIS REVIEWS, 1998, 17 (01) :7-23
[10]   Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite [J].
Gerlach, M ;
Keh, D ;
Bezold, G ;
Spielmann, S ;
Kürer, I ;
Peter, RU ;
Falke, KJ ;
Gerlach, H .
INTENSIVE CARE MEDICINE, 1998, 24 (11) :1199-1208